Search

everythinglearnresearchcommunity

for

Search:↓

PRP is safe but not more effective than a placebo for treating mild to moderate erectile dysfunction.

PRP is unlikely to effectively treat wrist ganglia.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Both treatments help with hair regrowth in alopecia areata, but azathioprine has milder side effects than betamethasone.

The 2% minoxidil nanosuspension is as effective as the commercial product but safer and easier to use.

Combining SVF cells with PRP may boost hair growth in androgenic alopecia.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Careful patient selection is key for effective pulse corticosteroid treatment in children with alopecia areata.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Bone marrow cells improved tendon health better than platelet-rich plasma.

A man with both skin lesions and lung cancer improved quickly with chemotherapy, suggesting the skin condition might be a reaction to immune system injury.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

2.5 mg/ml of triamcinolone acetonide is more effective for treating alopecia areata.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

Baricitinib 4 mg should be used for at least 1 year to see significant hair regrowth in severe alopecia areata.

Topical minoxidil, intralesional steroids, and cryotherapy significantly improve alopecia areata.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.